Remove Arrhythmia Remove Defibrillator Remove Sudden Cardiac Death
article thumbnail

MP-470553-004 ADVERSE EVENTS ASSOCIATED WITH WEARABLE CARDIOVERTER-DEFIBRILLATOR (LIFEVEST): A FOOD AND DRUG ADMINISTRATION MAUDE DATABASE STUDY

HeartRhythm

Wearable cardioverter-defibrillator (WCD) is an alternative option for the prevention of sudden cardiac death in patients at high risk for malignant ventricular arrhythmias.

article thumbnail

PO-02-168 EVALUATION OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ALGORITHM ACCURACY IN DIFFERENTIATING SUPRAVENTRICULAR TACHYCARDIA FROM ATRIAL FIBRILLATION.

HeartRhythm

For the past four decades, implantable cardioverter defibrillator (ICD) therapy has become the standard of care for preventing sudden cardiac death in high-risk individuals. The rate of ICD implantation has risen due to the increasing population age and the growing prevalence of cardiac arrhythmias.

article thumbnail

Inequities in access and use of automated external defibrillators

Heart BMJ

Sudden cardiac death is one of the main causes of mortality in patients with known or occult cardiac disease and is potentially preventable by early resuscitation.

article thumbnail

PO-02-098 PHENOTYPIC REFINEMENT OF SUDDEN DEATH BY AUTOPSY ENHANCES RISK ASSESSMENT FOR ARRHYTHMIC DEATH: FROM THE POST SCD STUDY

HeartRhythm

Studies of sudden cardiac death (SCD) risk intend to specify substrate for fatal arrhythmia rescuable by defibrillator but presume cardiac cause. The Postmortem Systematic Investigation of SCD (POST SCD) study showed nearly half of presumed SCDs (pSCDs) are due to non-arrhythmic causes (e.g.,

article thumbnail

Evaluation of patients with implantable cardioverter?defibrillator in a Latin American tertiary center

Journal of Cardiovascular Electrophysiology

Progressive decline across periods in mortality rates among patients with implantable cardioverter-defibrillator (ICD). Abstract Introduction Despite advancements in implantable cardioverter-defibrillator (ICD) technology, sudden cardiac death (SCD) remains a persistent public health concern.

article thumbnail

Ablation of Ventricular Tachycardia in Patients with ischemic cardiomyopathy and without an ICD – For the times they are a-changin´?

HeartRhythm

Most patients with VT and structural heart disease preparing for ablation either have or are about to receive an implantable cardioverter defibrillator (ICD) shortly after the procedure to prevent sudden cardiac death from recurrent ventricular arrhythmias (VA).

article thumbnail

Case Report: Lacosamide unmasking SCN5A-associated Brugada syndrome in a young female with epilepsy

Frontiers in Cardiovascular Medicine

During the intravenous lacosamide infusion, the patient developed sudden cardiac arrest caused by ventricular arrhythmias necessitating resuscitation. Of note, the patient had a family history of sudden cardiac death. 2893C>T, p.Arg965Cys) in the SCN5A gene.